Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
522.53 USD | -1.09% |
|
-0.63% | +7.66% |
Fiscal Period: October | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.69B | 4.2B | 5.08B | 5.84B | 6.13B | |||||
Total Revenues | 3.69B | 4.2B | 5.08B | 5.84B | 6.13B | |||||
Cost of Goods Sold, Total | 742M | 813M | 997M | 1.15B | 1.14B | |||||
Gross Profit | 2.94B | 3.39B | 4.08B | 4.7B | 4.99B | |||||
Selling General & Admin Expenses, Total | 917M | 1.04B | 1.13B | 1.3B | 1.43B | |||||
R&D Expenses | 1.28B | 1.5B | 1.68B | 1.95B | 2.08B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 91.28M | 82.38M | 96.69M | 103M | 124M | |||||
Other Operating Expenses, Total | 2.29B | 2.62B | 2.91B | 3.35B | 3.63B | |||||
Operating Income | 656M | 768M | 1.17B | 1.35B | 1.36B | |||||
Interest Expense, Total | -5.14M | -3.36M | -1.7M | -1.18M | -35.16M | |||||
Interest And Investment Income | 3.56M | 2.44M | 8.54M | 36.67M | 67.02M | |||||
Net Interest Expenses | -1.58M | -923K | 6.85M | 35.5M | 31.86M | |||||
Currency Exchange Gains (Loss) | 5.54M | 5.29M | 4.69M | -1.53M | 6.29M | |||||
Other Non Operating Income (Expenses) | 14.05M | 66.36M | -58.06M | -1.44M | 64.92M | |||||
EBT, Excl. Unusual Items | 674M | 839M | 1.13B | 1.38B | 1.46B | |||||
Restructuring Charges | -36.06M | -33.4M | -12.06M | -77M | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | 55.08M | |||||
Legal Settlements | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 638M | 806M | 1.12B | 1.3B | 1.51B | |||||
Income Tax Expense | -25.29M | 49.16M | 137M | 83.66M | 99.72M | |||||
Earnings From Continuing Operations | 663M | 756M | 978M | 1.22B | 1.41B | |||||
Earnings Of Discontinued Operations | - | - | - | - | 822M | |||||
Net Income to Company | 663M | 756M | 978M | 1.22B | 2.24B | |||||
Minority Interest | 900K | 1.16M | 6.16M | 11.76M | 27.57M | |||||
Net Income - (IS) | 664M | 758M | 985M | 1.23B | 2.26B | |||||
Net Income to Common Incl Extra Items | 664M | 758M | 985M | 1.23B | 2.26B | |||||
Net Income to Common Excl. Extra Items | 664M | 758M | 985M | 1.23B | 1.44B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.4 | 4.96 | 6.44 | 8.08 | 14.78 | |||||
Basic EPS - Continuing Operations | 4.4 | 4.96 | 6.44 | 8.08 | 9.41 | |||||
Basic Weighted Average Shares Outstanding | 151M | 153M | 153M | 152M | 153M | |||||
Net EPS - Diluted | 4.27 | 4.81 | 6.29 | 7.92 | 14.52 | |||||
Diluted EPS - Continuing Operations | 4.27 | 4.81 | 6.29 | 7.92 | 9.25 | |||||
Diluted Weighted Average Shares Outstanding | 156M | 157M | 156M | 155M | 156M | |||||
Normalized Basic EPS | 2.79 | 3.44 | 4.65 | 5.74 | 6.13 | |||||
Normalized Diluted EPS | 2.71 | 3.34 | 4.54 | 5.63 | 6.02 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 815M | 922M | 1.34B | 1.52B | 1.55B | |||||
EBITA | 700M | 805M | 1.21B | 1.38B | 1.38B | |||||
EBIT | 656M | 768M | 1.17B | 1.35B | 1.36B | |||||
EBITDAR | 913M | 1.02B | 1.44B | 1.63B | 1.66B | |||||
Total Revenues (As Reported) | 3.69B | 4.2B | 5.08B | 5.84B | 6.13B | |||||
Effective Tax Rate - (Ratio) | -3.96 | 6.1 | 12.29 | 6.43 | 6.59 | |||||
Current Domestic Taxes | 31.14M | 97.85M | 129M | 267M | 366M | |||||
Current Foreign Taxes | 55.1M | 79.89M | 45.3M | 27.99M | 110M | |||||
Total Current Taxes | 86.24M | 178M | 174M | 295M | 476M | |||||
Deferred Domestic Taxes | -105M | -107M | -40.57M | -110M | -352M | |||||
Deferred Foreign Taxes | -6.55M | -21.85M | 3.65M | -16.44M | -24.13M | |||||
Total Deferred Taxes | -112M | -129M | -36.91M | -127M | -376M | |||||
Normalized Net Income | 422M | 525M | 711M | 874M | 939M | |||||
Interest on Long-Term Debt | - | - | - | 1.18M | 35.16M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 632M | 712M | 780M | 889M | 859M | |||||
General and Administrative Expenses | 285M | 323M | 354M | 410M | 568M | |||||
Research And Development Expense From Footnotes | 1.33B | 1.55B | 1.75B | 2.02B | 2.19B | |||||
Net Rental Expense, Total | 98.78M | 102M | 104M | 117M | 116M | |||||
Imputed Operating Lease Interest Expense | 10.14M | 4.13M | 2.13M | 1.64M | 47.94M | |||||
Imputed Operating Lease Depreciation | 88.64M | 97.95M | 101M | 115M | 68.12M | |||||
Maintenance & Repair Expenses, Total | 62.1M | 62.6M | 72.9M | 84M | 89.4M | |||||
Stock-Based Comp., COGS (Total) | 36.52M | 52.16M | 79.28M | 94.79M | 98.59M | |||||
Stock-Based Comp., R&D Exp. (Total) | 126M | 171M | 242M | 294M | 359M | |||||
Stock-Based Comp., S&M Exp. (Total) | 43.2M | 61.94M | 81.62M | 107M | 122M | |||||
Stock-Based Comp., G&A Exp. (Total) | 43.04M | 60.16M | 56.15M | 67.77M | 78.58M | |||||
Total Stock-Based Compensation | 249M | 345M | 459M | 563M | 658M |